Form: S-3

Registration statement under Securities Act of 1933

November 18, 2026

 

Exhibit 5.1

 

Attorneys At Law

 

Corporate Center Three at International Plaza

4221 W. Boy Scout Boulevard | Suite 1000

Tampa, Florida 33607-5780

P.O. Box 3239 | Tampa, Florida 33601-3239

813.223.7000 | fax 813.229.4133

www.carltonfields.com

 

Atlanta

Florham Park

Hartford

Los Angeles

Miami

Minneapolis

New York

Orlando

Tallahassee

Tampa

Washington, DC

West Palm Beach

 

November 18, 2026

 

Abeona Therapeutics Inc.

6555 Carnegie Ave., 4th Floor

Cleveland, OH 44103

 

Re: Registration Statement on Form S-3
  Abeona Therapeutics Inc.

 

Ladies and Gentlemen:

 

We have acted as counsel to Abeona Therapeutics Inc., a corporation organized under the laws of the state of Delaware (the “Company”), in connection with the preparation and filing of the Company’s Registration Statement on Form S-3 (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”) and the related prospectus included in the Registration Statement (the “Prospectus”), covering the registration for resale of up to 12,494,426 shares (the “Shares”) of common stock, $0.01 par value per share (“Common Stock”), held or that may be acquired by those certain selling stockholders identified in the Prospectus (the “Selling Shareholders”).

 

The Shares consist of (i) 4,494,383 shares of Common Stock (“Acquisition Shares”) issued by the Company pursuant to that certain Asset Purchase Agreement, dated as of November 6, 2026 (the “APA”), by and between the Company and Ellodi Pharmaceuticals, L.P., a Delaware limited partnership, (ii) 6,400,000 shares of Common Stock (the “Private Placement Shares”) issued by the Company pursuant to that certain Securities Purchase Agreement dated November 6, 2026, by and among the Company and the purchasers signatory thereto (the “Securities Purchase Agreement”), and (iii) 1,600,043 shares of Common Stock (the “Warrant Shares”) issuable upon the exercise of outstanding pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”) issued by the Company (the “Pre-Funded Warrants”) pursuant to the Securities Purchase Agreement.

 

This opinion is being furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation S-K, 17 C.F.R. § 229.601(b)(5), promulgated under the Securities Act, in connection with the Registration Statement.

 

In rendering this opinion, we have examined and have relied upon originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, instruments, certificates or comparable documents of public officials and of officers and representatives of the Company, and other instruments as we have deemed relevant and necessary as a basis for the opinions hereinafter expressed, including without limitation, the following: (a) the APA, the Securities Purchase Agreement, and the Pre-Funded Warrants (collectively, the “Transactional Documents”); (b) the Certificate of Incorporation of the Company, as amended; (c) the Bylaws of the Company, as amended; (d) resolutions of the Board of Directors of the Company (the “Board”) relating to the authorization and issuance of the Shares by the Company pursuant to the terms of the Transaction Documents and related matters; and (e) the Registration Statement.

 

Carlton Fields, P.A.

Carlton Fields, P.A. practices law in California through Carlton Fields, LLP.

 

 
 

 

The opinions set forth below are subject to the following assumptions and qualifications, which are in addition to any other qualifications contained herein:

 

●We have assumed, without independent inquiry or investigation, the (i) genuineness of all signatures, (ii) legal capacity of all natural persons, (iii) authenticity of the documents purporting to be originals, and (iv) conformity to originals of all documents submitted to us as certified, conformed, or copies (including electronic files).

 

●We have assumed without independent verification (i) the accuracy, completeness, and authenticity of all corporate records made available to us by the Company and, (ii) with respect to facts material to the opinion below, we have relied on statements and representations of the officers and other representatives of the Company.

 

●The opinions expressed herein are limited to the Delaware General Corporation Law. We express no opinion as to the laws of any other jurisdiction, and we render no opinion regarding the statutes, administrative decisions, rules and regulations or requirements of or with respect to any county, municipality or subdivision or other local authority of any jurisdiction.

 

Based upon the foregoing, and in reliance thereon, we are of the opinion that (i) the Shares, other than the Warrant Shares, are validly issued, fully paid and nonassessable, and (ii) the Warrant Shares, when issued and paid for in accordance with the terms of the Pre-Funded Warrants, will be validly issued, fully paid and nonassessable.

 

This letter does not address any matters other than those expressly addressed herein. This opinion is limited to the laws in effect as of the date hereof and we undertake no responsibility to update or supplement this opinion after the date hereof.

 

We hereby consent to the filing of this opinion as exhibit 5.1 to the Registration Statement and to the reference to our firm under the caption Legal Matters in the Prospectus. By giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

 

  Very truly yours,
   
  /s/ CARLTON FIELDS, P.A.